NewsSOS
Pomerantz LLP said it is investigating claims on behalf of investors in NovoCure Limited (NASDAQ: NVCR), according to a release. The firm named Danielle Peyton as the contact attorney.
The release gave no description of the specific claims under review. Scope of the probe Pomerantz LLP identified NovoCure Limited, trading on Nasdaq under the symbol NVCR, as the subject of the inquiry.
No description of alleged misconduct was included, and the release cited no specific time period or regulatory action. It also did not indicate whether formal litigation has been filed.
How investors can reach the firm Peyton can be reached at 646-581-9980, extension 7980, or by email at newaction@pomlaw.com. The release listed New York as the firm's base for the announcement.
Keep reading